Study to Evaluate the Effect of Bimosiamose on Ozone Induced Sputum Neutrophilia

NCT00962481 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Bimosiamose
DRUG: Placebo

Sponsor

Revotar Biopharmaceuticals AG